Yellow Fever Vaccines
Yellow Fever Vaccines
Yellow fever vaccines provide protection from the yellow fever virus, an RNA virus from the family of Flaviviridae.
| Name | Description | Marketing Authorisation Holder | Kind of Vaccine | License Number | License Date | Further Information |
|---|---|---|---|---|---|---|
|
Stamaril |
Gelbfieber-Impfstoff Verwendung ab einem Lebensalter von 9 Monaten / Use from an age of 9 months |
EURIM-PHARM Arzneimittel GmbH |
Mono | PEI.H.11467.01.1 | 18.05.2011 | |
|
Stamaril |
Gelbfieber-Impfstoff Verwendung ab einem Lebensalter von 9 Monaten / Use from an age of 9 months |
kohlpharma GmbH |
Mono | PEI.H.11656.01.1 | 25.04.2013 | |
|
Stamaril |
Gelbfieber-Impfstoff Verwendung ab einem Lebensalter von 9 Monaten / Use from an age of 9 months |
EMRA-MED Arzneimittel GmbH |
Mono | PEI.H.11682.01.1 | 20.06.2013 | |
|
Stamaril |
Gelbfieber-Impfstoff Verwendung ab einem Lebensalter von 9 Monaten / Use from an age of 9 months |
Sanofi Pasteur Europe |
Mono | 178a/94 | 08.02.1996 |
Hints
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 477 in BAnz AT 16.02.2021 B7.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 01.03.2021
More Information
More Information
What are the age requirements for vaccines?
Altersangaben für Impfstoffe
Source: PEI
Updated: 01.03.2021
